info@seagull-health.com
SeagullHealth
语言:
search

How should I use Enasidenib(Idhifa)?

This section outlines the recommended dosing regimen and key administration instructions.

Recommended Dosage and Administration

The standard dosage of IDHIFA is 100 mg taken orally once daily, with or without food. Treatment should continue until disease progression or unacceptable toxicity occurs, with a minimum treatment duration of 6 months to allow for clinical response. Tablets must be swallowed whole. Dose modifications, including interruption or reduction to 50 mg daily, are required for specific toxicities such as differentiation syndrome, persistent hyperbilirubinemia, or other severe adverse reactions.

Enasidenib(Idhifa)
Enasidenib(Idhifa)
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adult...
WeChat Scan
Free Inquiry
Related articles
Dosage and Administration of Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory acute myeloid leuke...
Procurement Channels for Enasidenib
Enasidenib is a targeted medication for the treatment of relapsed or refractory acute myeloid leukemia (AML). Its rational use is of crucial importance to patients. Due to the specific nature of this ...
How to Use Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor used for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who harbor IDH2 mutations.How to Use Enas...
How to Use Enasidenib
Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who harbor an IDH2 mutation.How to U...
共 4 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved